Bookmark

Add to MyYahoo RSS

OXiGENE News

News on OXiGENE (Ticker: OXGN) continually updated from thousands of sources around the net.

Wednesday | BioSpace

OXiGENE Announces Presentation At The Rodman & Renshaw Conference On September 9

OXiGENE, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced that David Chaplin, Ph.D., CEO, will present a corporate overview at the Rodman and Renshaw Annual Global Investment conference on Tuesday, September 9, 2014 at 1:15 p.m. Eastern Time.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Aug 05, 2014

BioSpace

OXiGENE Reports Second Quarter 2014 Financial Results

OXiGENE, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, reported financial results for the quarter ended June 30, 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Oncology, Ovarian Cancer

Mon Jul 28, 2014

Seeking Alpha

CEO Departure And Recent Capital Raise At OXiGENE Reaffirms Bull Thesis

OXiGENE conducts recent $16 million secondary to bolster cash position and progress with likely Phase 3 study of its potential blockbuster Zyberstat/Avastin combination therapy.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Jul 23, 2014

GlobeNewswire

OXiGENE Announces Second Quarter 2014 Earnings Conference Call and Webcast

OXiGENE, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, will report second quarter 2014 results on Tuesday, August 5, 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••

Woodbridge Jobs

•••
•••
•••
•••